Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.43 and traded as high as $14.79. Nature's Sunshine Products shares last traded at $14.79, with a volume of 32,666 shares changing hands.
Nature's Sunshine Products Stock Down 3.3 %
The firm's 50 day moving average is $14.95 and its two-hundred day moving average is $14.42. The stock has a market cap of $261.68 million, a price-to-earnings ratio of 16.09 and a beta of 0.96.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.27 earnings per share for the quarter. Nature's Sunshine Products had a return on equity of 11.08% and a net margin of 3.81%. The business had revenue of $114.62 million for the quarter.
Hedge Funds Weigh In On Nature's Sunshine Products
Several institutional investors have recently modified their holdings of NATR. Wasatch Advisors LP boosted its stake in Nature's Sunshine Products by 23.2% during the 3rd quarter. Wasatch Advisors LP now owns 696,184 shares of the company's stock valued at $9,482,000 after purchasing an additional 131,174 shares during the period. Barclays PLC boosted its position in Nature's Sunshine Products by 51.8% during the 3rd quarter. Barclays PLC now owns 35,602 shares of the company's stock worth $485,000 after acquiring an additional 12,152 shares during the period. Franklin Resources Inc. boosted its position in Nature's Sunshine Products by 4.3% during the 3rd quarter. Franklin Resources Inc. now owns 20,744 shares of the company's stock worth $270,000 after acquiring an additional 856 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Nature's Sunshine Products by 24.3% in the third quarter. JPMorgan Chase & Co. now owns 34,633 shares of the company's stock worth $472,000 after purchasing an additional 6,769 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its holdings in shares of Nature's Sunshine Products by 7.7% during the third quarter. Jacobs Levy Equity Management Inc. now owns 67,258 shares of the company's stock valued at $916,000 after purchasing an additional 4,820 shares during the period. Institutional investors own 79.40% of the company's stock.
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Recommended Stories
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
